| Previous close | 18.01 |
| Open | 18.13 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 18.02 - 18.34 |
| 52-week range | 17.75 - 21.40 |
| Volume | |
| Avg. volume | 94,328 |
| Market cap | 758.057M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.09 |
| Earnings date | N/A |
| Forward dividend & yield | 1.35 (7.50%) |
| Ex-dividend date | 19 May 2023 |
| 1y target est | N/A |
BOSTON, May 31, 2023--On May 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of
BOSTON, May 10, 2023--On May 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is May 22, 2023 and the payable date is May 31, 2023. The Fund will trade ex-distribution on May 19, 2023.
BOSTON, March 31, 2023--On March 31, 2023, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized depreciation of portfolio securities and net realized losses on
BOSTON, March 31, 2023--On March 31, 2023, Tekla Healthcare Investors paid a distribution of $0.42 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of
BOSTON, March 31, 2023--On March 31, 2023, Tekla Life Sciences Investors paid a distribution of $0.33 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale
BOSTON, March 16, 2023--Tekla Healthcare Opportunities Fund (the "Fund") announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2023. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2024. The Board